Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

The Precision Peptide Company Inc. PNGAF

Set alert

Price alert · PNGAF

All alert types
0.20 USD +0.01 +3.77%

At close · Oct 30

0.2204 Day range 0.24
0.0077 52-week range 0.4099
YTD
-0.73%
1 year
+45.42%
Open
0.24
Prev close
0.19745
Mkt cap
11.40M
Vol
7.50K
Avg vol
35.58K
EPS
-0.15
P/E
0.00
More statistics
Low
0.2204
High
0.24

5D chart

Chart tools
Interval
1m5m15m30m

Signals (6)
NameTimeAgo
MACD: Buy SignalOct 29, 9:30 AM3 days ago
RSI: OverboughtOct 29, 9:30 AM3 days ago
MACD: Sell SignalOct 28, 1:40 PM3 days ago
MACD: Buy SignalOct 28, 12:00 PM3 days ago
SMA: BullishOct 28, 11:50 AM3 days ago
SMA: BullishOct 28, 11:50 AM3 days ago

Financial health

Altman Z-Score

-3.34 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.9×
FY 2021: -76.1×FY 2022: -3.4×FY 2023: -2.9×FY 2024: -0.3×FY 2025: -1.9×
FY 2021 5y median -2.9× FY 2025
P/S 177×
FY 2021: 194×FY 2022: 5.6×FY 2023: 16.6×FY 2024: 24.5×FY 2025: 177×
FY 2021 5y median 24.5× FY 2025
P/B 9.4×
FY 2021: 10.8×FY 2022: 18.3×FY 2023: -34.3×FY 2024: -0.5×FY 2025: 9.4×
FY 2021 5y median 9.4× FY 2025
P/FCF -3.8×
FY 2021: -22.5×FY 2022: -5.3×FY 2023: -4.8×FY 2024: -0.7×FY 2025: -3.8×
FY 2021 5y median -4.8× FY 2025
EV/EBITDA -3.6×
FY 2021: -72.3×FY 2022: -4.2×FY 2023: -2.9×FY 2024: -0.2×FY 2025: -3.6×
FY 2021 5y median -3.6× FY 2025
EV/Sales 157×
FY 2021: 182×FY 2022: 5.4×FY 2023: 16.4×FY 2024: 14.5×FY 2025: 157×
FY 2021 5y median 16.4× FY 2025
FCF Yield -26.5%
FY 2021: -4.5%FY 2022: -18.7%FY 2023: -20.7%FY 2024: -147.0%FY 2025: -26.5%
FY 2021 5y median -20.7% FY 2025

Profitability

Gross Margin -139.1%
FY 2021: -98.2%FY 2022: 5.9%FY 2023: -11.5%FY 2024: 56.6%FY 2025: -139.1%
FY 2021 5y median -11.5% FY 2025
Operating Margin -4530.1%
FY 2021: -252.9%FY 2022: -95.0%FY 2023: -575.4%FY 2024: -7545.5%FY 2025: -4530.1%
FY 2021 5y median -575.4% FY 2025
Net Margin -9104.5%
FY 2021: -252.9%FY 2022: -230.0%FY 2023: -581.4%FY 2024: -8450.2%FY 2025: -9104.5%
FY 2021 5y median -581.4% FY 2025
ROE -486.9%
FY 2021: -14.1%FY 2022: -758.4%FY 2023: 1200.7%FY 2024: 187.3%FY 2025: -486.9%
FY 2021 5y median -14.1% FY 2025
ROIC -242.3%
FY 2021: -14.1%FY 2022: -313.3%FY 2023: 1188.4%FY 2024: 172.9%FY 2025: -242.3%
FY 2021 5y median -14.1% FY 2025
ROA -340.1%
FY 2021: -12.9%FY 2022: -258.9%FY 2023: -866.0%FY 2024: -565.6%FY 2025: -340.1%
FY 2021 5y median -340.1% FY 2025

Growth (YoY)

Revenue 307.4%
FY 2021: 0.0%FY 2022: 919.4%FY 2023: -59.1%FY 2024: -95.7%FY 2025: 307.4%
FY 2021 FY 2025
Operating Income -144.6%
FY 2021: 0.0%FY 2022: -283.1%FY 2023: -147.7%FY 2024: 44.0%FY 2025: -144.6%
FY 2021 FY 2025
EPS (diluted) -40.0%
FY 2021: 0.0%FY 2022: -543.7%FY 2023: -18.2%FY 2024: -208.0%FY 2025: -40.0%
FY 2021 FY 2025
Free Cash Flow -429.9%
FY 2021: 0.0%FY 2022: -22.9%FY 2023: -35.1%FY 2024: 55.2%FY 2025: -429.9%
FY 2021 FY 2025

Financial Health

Current Ratio 3.3×
FY 2021: 11.0×FY 2022: 1.4×FY 2023: 0.5×FY 2024: 0.2×FY 2025: 3.3×
FY 2021 5y median 1.4× FY 2025
Quick Ratio 3.1×
FY 2021: 10.9×FY 2022: 1.2×FY 2023: 0.4×FY 2024: 0.2×FY 2025: 3.1×
FY 2021 5y median 1.2× FY 2025
Debt / Equity 0.0×
FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 0.4×
FY 2021: 4.7×FY 2022: 0.1×FY 2023: 0.0×FY 2024: 0.1×FY 2025: 0.4×
FY 2021 5y median 0.1× FY 2025
Interest Coverage 0.0×
FY 2021: 0.0×FY 2022: -1.4×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2021 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-10-31